GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » PB Ratio

Optipharm Co (XKRX:153710) PB Ratio : 4.02 (As of May. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Optipharm Co's share price is ₩6890.00. Optipharm Co's Book Value per Share for the quarter that ended in Dec. 2023 was ₩1,714.00. Hence, Optipharm Co's PB Ratio of today is 4.02.

Good Sign:

Optipharm Co Ltd stock PB Ratio (=3.96) is close to 1-year low of 3.58

The historical rank and industry rank for Optipharm Co's PB Ratio or its related term are showing as below:

XKRX:153710' s PB Ratio Range Over the Past 10 Years
Min: 2.08   Med: 4.29   Max: 11.29
Current: 3.96

During the past 11 years, Optipharm Co's highest PB Ratio was 11.29. The lowest was 2.08. And the median was 4.29.

XKRX:153710's PB Ratio is ranked worse than
78.64% of 206 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.155 vs XKRX:153710: 3.96

During the past 12 months, Optipharm Co's average Book Value Per Share Growth Rate was -13.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -9.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -4.10% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Optipharm Co was 72.70% per year. The lowest was -46.80% per year. And the median was -6.20% per year.

Back to Basics: PB Ratio


Optipharm Co PB Ratio Historical Data

The historical data trend for Optipharm Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optipharm Co PB Ratio Chart

Optipharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.65 6.51 4.44 3.54 4.10

Optipharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 4.04 4.13 4.07 4.10

Competitive Comparison of Optipharm Co's PB Ratio

For the Diagnostics & Research subindustry, Optipharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optipharm Co's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optipharm Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Optipharm Co's PB Ratio falls into.



Optipharm Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Optipharm Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=6890.00/1713.997
=4.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Optipharm Co  (XKRX:153710) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Optipharm Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Optipharm Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Optipharm Co (XKRX:153710) Business Description

Traded in Other Exchanges
N/A
Address
6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR
Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.

Optipharm Co (XKRX:153710) Headlines

No Headlines